GSK343

Intervention

1 paper4 findings

PubChemChEBI

  • 1 lab in 1 country
  • Funders: Colorado Clinical & Translational Sciences Institute and 1 more
  • Cells1

Outcomes

4

Primary chondrocyte proliferation

upin human cells1

1 study
  1. GSK343 increases primary chondrocyte proliferation in human cells.

    “Functionally, conditioned media from GSK343-treated MSCs significantly increased primary chondrocyte proliferation, demonstrating preserved therapeutic potency.”

    Cellsconditioned media from GSK343-treated MSCs

    Mechanoepigenetic Targeting of Histone Methyltransferase EZH2 Increases Potential of Scalable Manufacturing in Human Derived Primary Mesenchymal Stromal Cells

    bioRxiv : the preprint server for biology12 Dec 2025Preprint

Cellular senescence

downin human cells1

1 study
  1. GSK343 inhibits cellular senescence in human cells.

    “RNA-seq demonstrated that GSK343 maintained transcriptional programs associated with immunomodulation, migration, and trophic signaling, while suppressing hyperproliferative and senescence-associated genes that are characteristic of late-passage MSCs.”

    Cellsin late-passage MSCs

    Mechanoepigenetic Targeting of Histone Methyltransferase EZH2 Increases Potential of Scalable Manufacturing in Human Derived Primary Mesenchymal Stromal Cells

    bioRxiv : the preprint server for biology12 Dec 2025Preprint

More on Cellular senescence

Stem cell maintenance

upin human cells1

1 study
  1. GSK343 improves stem cell maintenance in human cells.

    “Pharmacological inhibition of EZH2 with GSK343 selectively reduced H3K27me3, restored ARID1A-containing SWI/SNF organization, and preserved MSC morphology and expression of canonical stemness markers (CD73, CD90, CD105) even at later passage.”

    Cellsat later passage during expansion

    Mechanoepigenetic Targeting of Histone Methyltransferase EZH2 Increases Potential of Scalable Manufacturing in Human Derived Primary Mesenchymal Stromal Cells

    bioRxiv : the preprint server for biology12 Dec 2025Preprint

More on Stem cell maintenance

H3K27me3

downin human cells1

1 study
  1. GSK343 decreases H3K27me3 in human cells.

    “Pharmacological inhibition of EZH2 with GSK343 selectively reduced H3K27me3, restored ARID1A-containing SWI/SNF organization, and preserved MSC morphology and expression of canonical stemness markers (CD73, CD90, CD105) even at later passage.”

    Cellsin-vitro expansion on standard tissue-culture plastic

    Mechanoepigenetic Targeting of Histone Methyltransferase EZH2 Increases Potential of Scalable Manufacturing in Human Derived Primary Mesenchymal Stromal Cells

    bioRxiv : the preprint server for biology12 Dec 2025Preprint

More on H3K27me3

Latest

Nov 2025: 0Dec 2025: 1Jan 2026: 0Feb 2026: 0Mar 2026: 0Apr 2026: 0May 2026: 0Jun 2026: 0Jul 2026: 0Aug 2026: 0Sep 2026: 0Oct 2026: 01 in 12 months